Bionano Genomics Inc.’s stock (NASDAQ:BNGO) has been rated as Outperform by Oppenheimer. This latest rating was contained in a recent research note published by the firm on April 08, 2020 and has set a $1.50 price target for the stock.
As it stands, a total of 2 analysts are covering BNGO stock, with 2 of them rating it as a Buy while 0 of them rating it as Overweight. 0 analysts meanwhile advised investors to Hold, 0 rated it as Underweight while the 0 rated it as a Sell. A look at the overall ratings means that Bionano Genomics Inc. (BNGO) stock has an average rating of Buy.
Bionano Genomics Inc. (BNGO) which is currently valued at 13.71 million, with the company publishing its last earnings report on 03/06/2020, for the recent quarter of 2019. In that quarter, the company recorded a revenue of 2.79 million, which was lower than the forecast of 4.71 million made by some analysts. For that same quarter, Bionano Genomics Inc. (BNGO) posted -$0.62 earnings per share (EPS) which was below the analyst consensus estimate of -$0.46 by -$0.16, which represents a decrease by -34.80%.
The stock market has a tendency to become sophisticated sometimes, even for seasoned investors and traders. Even when a trader got what he/she had expected, the market sometimes decides to move in the opposite direction. This volatility sometimes leads to some traders doubting and second-guessing their moves. This is why getting to know historical price performance, as well as both long-term and short-term trends, is very important. Over the past one week, BNGO price has surged by 25.58%. A look at its price performance over the past three months sees the stock go down by -67.52%, while it has lost -30.98% over the past six months and -90.45% since the start of the year.
Let us now look at some of its likely support and resistance level. Recent research on Bionano Genomics Inc. (BNGO) has seen its stock trading -70.99% below its three-month high price. A look at the other side also sees stock trading +52.00% above its three-month low. A wider look sees BNGO trading -70.99% below its 52-week high and 52.00% above from its 52-week low price.
The Return on Assets (ROA) ratio meanwhile is an indication of how profitable a company is relative to the total asset it owns. Bionano Genomics Inc. (BNGO)’s ROA at the moment stands at -114.50%. Any company that is managing its assets better will have a higher return while one that manages assets poorly would result in low returns.
Bionano Genomics Inc. (BNGO) has a return on investment (ROI) of -114.90%. The higher the ROI percentage, the higher the profit exceeds the costs, thus analysts consider such investments as an overall gain. A negative ROI, however, means that the cost is higher than the profits, a scenario analysts consider as a net loss.
Let us now take a look at Bionano Genomics Inc. (BNGO)’s trading volatility. Its 7-day volatility is around 14.71%, while it has a monthly volatility of 16.42%. BNGO has an ATR (Average True Range) of 0.08. The volatility of a stock is an indication of the stock’s drop or gain in case the wider market drops or surges. A beta score higher than 1 means that a stock is highly volatile while below 1 means that the volatility of a stock is low.
The price of BNGO moved down by -$0.01 during the normal trading session on Thursday to trade at $0.38. The Bionano Genomics Inc. (BNGO) stock has a trading volume of 6.64 million shares, which is high, compared to its average daily volume of 3.65M shares.